Cabot Co. (NYSE:CBT) Receives Consensus Rating of “Hold” from Brokerages

Shares of Cabot Co. (NYSE:CBT) have been assigned a consensus rating of “Hold” from the five research firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $90.17.

A number of equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Cabot from a “buy” rating to a “hold” rating and raised their price objective for the company from $88.00 to $95.00 in a research report on Thursday, April 18th. UBS Group downgraded shares of Cabot from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $90.00 to $87.00 in a research report on Monday, January 8th. StockNews.com downgraded shares of Cabot from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 14th. Finally, Mizuho assumed coverage on shares of Cabot in a research report on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price objective for the company.

Insider Activity

In other news, EVP Jeff Ji Zhu sold 55,233 shares of Cabot stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the completion of the sale, the executive vice president now directly owns 97,201 shares in the company, valued at approximately $7,767,331.91. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 3.07% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Ronald Blue Trust Inc. lifted its stake in Cabot by 460.7% in the 3rd quarter. Ronald Blue Trust Inc. now owns 1,895 shares of the specialty chemicals company’s stock valued at $127,000 after buying an additional 1,557 shares in the last quarter. SG Americas Securities LLC lifted its stake in Cabot by 416.6% in the 3rd quarter. SG Americas Securities LLC now owns 21,535 shares of the specialty chemicals company’s stock valued at $1,492,000 after buying an additional 17,366 shares in the last quarter. Raymond James & Associates lifted its stake in Cabot by 5.0% in the 3rd quarter. Raymond James & Associates now owns 41,878 shares of the specialty chemicals company’s stock valued at $2,901,000 after buying an additional 1,986 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Cabot by 18.8% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,476 shares of the specialty chemicals company’s stock valued at $795,000 after buying an additional 1,819 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its stake in Cabot by 17.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 175,336 shares of the specialty chemicals company’s stock valued at $12,146,000 after buying an additional 26,052 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.

Cabot Stock Performance

Shares of CBT stock opened at $93.42 on Thursday. The stock’s 50-day moving average is $88.80 and its two-hundred day moving average is $80.17. The firm has a market cap of $5.18 billion, a price-to-earnings ratio of 12.13, a PEG ratio of 0.98 and a beta of 1.28. Cabot has a 1 year low of $63.73 and a 1 year high of $98.34. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.30 and a current ratio of 2.04.

Cabot (NYSE:CBT) last issued its quarterly earnings data on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.07. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The company had revenue of $958.00 million for the quarter, compared to analyst estimates of $927.28 million. Analysts predict that Cabot will post 6.58 earnings per share for the current year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.